AU2002241189A1 - Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides - Google Patents
Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotidesInfo
- Publication number
- AU2002241189A1 AU2002241189A1 AU2002241189A AU2002241189A AU2002241189A1 AU 2002241189 A1 AU2002241189 A1 AU 2002241189A1 AU 2002241189 A AU2002241189 A AU 2002241189A AU 2002241189 A AU2002241189 A AU 2002241189A AU 2002241189 A1 AU2002241189 A1 AU 2002241189A1
- Authority
- AU
- Australia
- Prior art keywords
- polynucleotides
- polypeptides
- methods
- growth factor
- stem cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000010261 cell growth Effects 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2001227385 | 2000-12-23 | ||
| PCT/US2000/035260 WO2001053500A1 (en) | 1999-12-23 | 2000-12-23 | Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| PCT/IB2001/002839 WO2002051868A2 (en) | 2000-12-23 | 2001-07-25 | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002241189A1 true AU2002241189A1 (en) | 2002-07-08 |
Family
ID=21742103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002241189A Abandoned AU2002241189A1 (en) | 2000-12-23 | 2001-07-25 | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060074044A1 (https=) |
| EP (1) | EP1345965A2 (https=) |
| JP (1) | JP2004518425A (https=) |
| AU (1) | AU2002241189A1 (https=) |
| WO (1) | WO2002051868A2 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4491632A (en) * | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
| US4444887A (en) * | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| US4341761A (en) * | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
| US4472506A (en) * | 1981-01-13 | 1984-09-18 | Liburdy Robert P | Method for determining cell membrane dielectric breakdown |
| US4466917A (en) * | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| US4493890A (en) * | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
| US4451570A (en) * | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
| US4399121A (en) * | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
| US4427783A (en) * | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
| ATE448246T1 (de) * | 1999-06-15 | 2009-11-15 | Genentech Inc | Sekretierte und transmembran-polypeptide sowie nukleinsäuren zu deren kodierung |
| ATE355305T1 (de) * | 1999-12-23 | 2006-03-15 | Kirin Brewery | Verfahren und materialien bezüglich stammzell wachstumsfaktor ähnlichen polypeptiden und polynukleotiden |
| US6569662B1 (en) * | 2000-01-21 | 2003-05-27 | Hyseq, Inc. | Nucleic acids and polypeptides |
| CA2416732C (en) * | 2000-08-02 | 2016-02-09 | Brad St. Croix | Endothelial cell expression patterns |
-
2001
- 2001-07-25 JP JP2002552961A patent/JP2004518425A/ja not_active Withdrawn
- 2001-07-25 WO PCT/IB2001/002839 patent/WO2002051868A2/en not_active Ceased
- 2001-07-25 EP EP01988101A patent/EP1345965A2/en not_active Withdrawn
- 2001-07-25 AU AU2002241189A patent/AU2002241189A1/en not_active Abandoned
-
2005
- 2005-11-18 US US11/283,290 patent/US20060074044A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1345965A2 (en) | 2003-09-24 |
| JP2004518425A (ja) | 2004-06-24 |
| WO2002051868A3 (en) | 2003-05-30 |
| US20060074044A1 (en) | 2006-04-06 |
| WO2002051868A2 (en) | 2002-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001274871A1 (en) | Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides | |
| AU5904101A (en) | Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides | |
| IL156234A0 (en) | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same | |
| AU2002239712A1 (en) | Polypeptides having glucoamylase activity and nucleic acids encoding same | |
| AU2002245117A1 (en) | In vitro-derived adult pluripotent stem cells and uses therefor | |
| AU2001286315A1 (en) | Stem cell-like cells | |
| AU2003224702A1 (en) | Stem cell selection and differentiation | |
| AU6768301A (en) | Materials and methods relating to the increase in protein activity | |
| AU2001290322A1 (en) | Fuel cell and production method therefor | |
| AU2001290078A1 (en) | Stem cell therapy | |
| AU2001247880A1 (en) | Methods to prepare and use epidermal stem cells | |
| AU2001292318A1 (en) | Fuel cell and production method therefor | |
| AU2001227385A1 (en) | Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides | |
| AU2001250966A1 (en) | Pluripotential stem cells | |
| AU6762800A (en) | Methods and materials relating to cd39-like polypeptides | |
| GB0025088D0 (en) | Stem cells | |
| AU2001259041A1 (en) | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides | |
| AU2002241189A1 (en) | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides | |
| AU2149899A (en) | Process for making desired polypeptides in yeast | |
| AU2002323137A1 (en) | Methods and compositions for use in selectively producing a protein in telomerase expressing cells | |
| AU2001232967A1 (en) | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides | |
| AU1782601A (en) | Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides | |
| AU2822999A (en) | Protein expression in floral cells | |
| AU2002223038A1 (en) | Nucleic acids and polypeptides specifically expressed in cells of the transfer zone of a plant seed and uses thereof | |
| AU2002333706A1 (en) | Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |